Research - Beijing, Beijing, China
Sironax is a clinical stage biotech company that discovers and develops transformational therapies for degenerative, neurological, and inflammatory diseases. Current pipeline portfolio consists of multiple programs targeting critical pathways underlying degenerative disease pathogenesis. The company has operations in both China and the U.S., and is financially supported by a syndicate of global top tier investors. More information can be found at https://www.sironax.com
Outlook
Apache
OpenSSL
Bootstrap Framework
Mobile Friendly